ID: ALA4764919

Max Phase: Preclinical

Molecular Formula: C13H18O3

Molecular Weight: 222.28

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCc1cccc(O)c1C(=O)O

Standard InChI:  InChI=1S/C13H18O3/c1-2-3-4-5-7-10-8-6-9-11(14)12(10)13(15)16/h6,8-9,14H,2-5,7H2,1H3,(H,15,16)

Standard InChI Key:  XXWAOOWYHQQGJJ-UHFFFAOYSA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 222.28Molecular Weight (Monoisotopic): 222.1256AlogP: 3.21#Rotatable Bonds: 6
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.64CX Basic pKa: CX LogP: 4.71CX LogD: 1.21
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.73Np Likeness Score: 0.80

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source